Stocks In Focus: ResMed, March 18 2026
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Stocks In Focus: ResMed, March 18 2026
-
Narrated by:
-
By:
This week, Scott talks to Motley Fool Director of Research, Ryan Newman, about medical device maker, ResMed (ASX:RMD).
See omnystudio.com/listener for privacy information.
No reviews yet